New Drug for Crohn’s Disease Shows Early Promise
But findings are preliminary, experts point outContinue Reading
But findings are preliminary, experts point outContinue Reading
The drugs are use to treat delusions, hallucinations, agitation and aggressionContinue Reading
The new therapies have remarkably high cure ratesContinue Reading
They had much higher risk of heart attack, stroke or death than nonsmokers or those who quitContinue Reading
They had much higher risk of heart attack, stroke or death than nonsmokers or those who quitContinue Reading
Those who suffered milder type of heart attack or unstable chest pain did worse if only given medicationContinue Reading
Effect was seen in study of current and former smokersContinue Reading
Expert offers tips to minimize discomfortContinue Reading
Adding the ‘investigational biologic’ evolocumab to statin therapy works better, study saysContinue Reading
Company-funded trial finds lower rates of heart attack, death with Brilinta versus placeboContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.